Quipt Home Medical Corp. (NASDAQ:QIPT) Shares Purchased by Royce & Associates LP

Royce & Associates LP increased its stake in shares of Quipt Home Medical Corp. (NASDAQ:QIPT - Free Report) by 15.8% in the 3rd quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The firm owned 1,768,789 shares of the company's stock after purchasing an additional 240,980 shares during the quarter. Royce & Associates LP owned 4.10% of Quipt Home Medical worth $5,165,000 as of its most recent SEC filing.

Several other hedge funds have also recently modified their holdings of the stock. ProShare Advisors LLC purchased a new position in shares of Quipt Home Medical in the second quarter valued at $35,000. SG Americas Securities LLC purchased a new position in shares of Quipt Home Medical in the third quarter valued at $44,000. Price T Rowe Associates Inc. MD increased its position in shares of Quipt Home Medical by 25.9% in the first quarter. Price T Rowe Associates Inc. MD now owns 12,829 shares of the company's stock valued at $57,000 after buying an additional 2,640 shares in the last quarter. Rhumbline Advisers increased its position in shares of Quipt Home Medical by 21.0% in the second quarter. Rhumbline Advisers now owns 49,276 shares of the company's stock valued at $159,000 after buying an additional 8,541 shares in the last quarter. Finally, Hsbc Holdings PLC increased its position in shares of Quipt Home Medical by 10.4% in the second quarter. Hsbc Holdings PLC now owns 52,522 shares of the company's stock valued at $165,000 after buying an additional 4,969 shares in the last quarter. 42.85% of the stock is owned by institutional investors and hedge funds.

Quipt Home Medical Stock Performance

Quipt Home Medical stock remained flat at $2.45 during midday trading on Tuesday. The company had a trading volume of 94,811 shares, compared to its average volume of 189,548. The company's 50-day moving average is $2.75 and its 200-day moving average is $3.08. The company has a quick ratio of 0.77, a current ratio of 1.11 and a debt-to-equity ratio of 0.66. Quipt Home Medical Corp. has a 1 year low of $2.43 and a 1 year high of $5.29. The firm has a market capitalization of $105.57 million, a P/E ratio of -22.27 and a beta of 0.62.

Analyst Ratings Changes

A number of research analysts have recently weighed in on the company. Canaccord Genuity Group dropped their price target on Quipt Home Medical from $8.00 to $6.00 and set a "buy" rating for the company in a research report on Friday, August 16th. Benchmark dropped their price objective on Quipt Home Medical from $9.00 to $7.00 and set a "buy" rating for the company in a research report on Wednesday, August 21st. One analyst has rated the stock with a sell rating, three have assigned a buy rating and two have issued a strong buy rating to the company's stock. According to MarketBeat, the company presently has an average rating of "Buy" and an average target price of $6.25.

About Quipt Home Medical

Quipt Home Medical Corp., through its subsidiaries, engages in the provision of durable and home medical equipment and supplies in the United States. The company offers nebulizers, oxygen concentrators, and CPAP and BiPAP units; traditional and non-traditional durable medical respiratory equipment and services; non-invasive ventilation equipment, supplies, and services; and engages in the rental of medical equipment.